QuickView for YDL103C;jsessionid=15F15BB478DC6C77651BC16CE76A6F8A;jsessionid=FA09DD4A5D65571BA1AD979499E356E2;jsessionid=5DB5107377C50D220B2B02849FAC3A0E;jsessionid=2766B9A4379564671E9BCB65AB596CAF;jsessionid=A06FF884E94C89B37D11661C0B1FCC3D;jsessionid=C52786C8B2B8DB64911C7275F9BAEEA6;jsessionid=BE7A20602B38335168FBEE85C2EAE01C;jsessionid=9451A13F423B4FE218F390CCAA7B0790;jsessionid=8C4921DD70EB5C8B0D8FF92519D85D9D;jsessionid=A38CFC6E55C3039792CA71D02AE534DC (gene)

1. Cyst fluid glycoproteins accurately distinguishing malignancies of pancreatic cystic neoplasm.
2. Clinical Evaluation of Cystic Renal Masses With Bosniak Classification by Contrast-Enhanced Ultrasou…
3. Feasibility of Surveillance for Mucinous Cystic Neoplasm of the Pancreas: A Multi-Institutional Retr…
4. Clinicopathological and genetic characteristics of congenital cystic adenomatoid malformation of lun…
5. The added value of contrast-enhanced ultrasound in evaluation of indeterminate small solid renal mas…

There were no clinical trials for YDL103C;jsessionid=15F15BB478DC6C77651BC16CE76A6F8A;jsessionid=FA09DD4A5D65571BA1AD979499E356E2;jsessionid=5DB5107377C50D220B2B02849FAC3A0E;jsessionid=2766B9A4379564671E9BCB65AB596CAF;jsessionid=A06FF884E94C89B37D11661C0B1FCC3D;jsessionid=C52786C8B2B8DB64911C7275F9BAEEA6;jsessionid=BE7A20602B38335168FBEE85C2EAE01C;jsessionid=9451A13F423B4FE218F390CCAA7B0790;jsessionid=8C4921DD70EB5C8B0D8FF92519D85D9D;jsessionid=A38CFC6E55C3039792CA71D02AE534DC